Startup AxoSim Technologies has been awarded a $225,000 Small Business Technology Transfer grant by the NIH. This one-year grant will fund additional research to demonstrate that AxoSim’s novel nerve-on-a-chip technology can improve drug development in the pharmaceutical industry and in the chemotherapy space in particular.

March 9, 2016 — Read more in the Times-Picayune